Click here to view the United Healthcare (UHC) Medical Policy Updates » September 2024 United…
Blue Shield California Medical Policy Updates – December 2018
Click here to view the Blue Shield California Medical Policy Updates »
December 2018 Blue Shield California Medical Policy Updates:
- Absorbable Nasal Implant for Treatment of Nasal Valve Collapse
- Antigen Leukocyte Antibody Test
- BCR-ABL1 Testing in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia
- Charged-Particle (Proton or Helium Ion) Radiotherapy for Neoplastic Conditions
- Circulating Tumor DNA for Management of Non-Small-Cell Lung Cancer (Liquid Biopsy
- Circulating Tumor DNA for Management of Non-Small-Cell Lung Cancer (Liquid Biopsy)
- Clostridial Collagenase for Fibroproliferative Disorders
- Dopamine Transporter Imaging with Single-Photon Emission Computed Tomography
- Expanded Molecular Panel Testing of Cancers to Identify Targeted Therapies
- External Insulin Infusion Pump
- Extracorporeal Photopheresis
- Genetic Cancer Susceptibility Panels Using Next-Generation Sequencing
- Genetic Testing for Developmental Delay/Intellectual Disability
- Genetic Testing for Heterozygous Familial Hypercholesterolemia
- Genetic Testing for Lipoprotein(a) Variant(s) as a Decision Aid for Aspirin Treatment
- Hyperthermic Intraperitoneal Chemotherapy for Select Intra- Abdominal and Pelvic Malignancies
- Interspinous and Interlaminar Stabilization/Distraction Devices (Spacers)
- Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease
- Knee Arthroscopy
- Laboratory Tests for Heart Transplant Rejection
- Magnetic Esophageal Sphincter Augmentation to Treat Gastroesophageal Reflux Disease
- Microarray-Based Gene Expression Profile Testing for Multiple Myeloma Risk Stratification
- Molecular Analysis for Targeted Therapy of Non-Small-Cell Lung Can
- Molecular Testing for the Management of Pancreatic Cysts or Barrett Esophagus
- Next-Generation Sequencing for the Assessment of Measurable Residual Disease
- Partial Thickness Rotator Cuff Tears and Acromioplasty/Subacromial Decompression
- Quantitative Electroencephalography as a Diagnostic Aid for Attention-Deficit/Hyperactivity Disorder
- Stereotactic Radiosurgery and Stereotactic Body Radiotherapy
- Transcranial Magnetic Stimulation as a Treatment of Depression and Other Psychiatric/Neurologic Disorders
- Use of Common Genetic Variants (Single Nucleotide Variants) to Predict Risk of Nonfamilial Breast Cancer
- Whole Exome and Whole Genome Sequencing for Diagnosis of Genetic Disorders
Click here to view the Blue Shield California Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
